Use of a novel biosignature score results in de-escalation of adjuvant radiation therapy in patients undergoing breast-conserving surgery for ductal carcinoma in situ (DCIS)

ANNALS OF SURGICAL ONCOLOGY(2022)

引用 0|浏览9
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要